Vol 4, No 2 (2003) - Practical Diabetology

Date published: 2003-04-28

Table of Contents

open access

Original articles (submitted)

The DINAMIC 2 study: aims, assumptions and methods (I)

Jacek Sieradzki, Władysław Grzeszczak, Teresa Kasperska-Czyżyk, Marcin Szczepański

Diabetologia Praktyczna 2003;4(2):97-102.

The DINAMIC 2 results in Poland (II)

Jacek Sieradzki, Teresa Kasperska-Czyżyk, Władysław Grzeszczak, Marcin Szczepański oraz Zespół Badaczy DINAMIC

Diabetologia Praktyczna 2003;4(2):103-110.

DINAMIC 2 study: results of comparison among various regions of Poland (III)

Władysław Grzeszczak, Jacek Sieradzki, Teresa Kasperska-Czyżyk, Marcin Szczepański oraz Zespół Badaczy DINAMIC

Diabetologia Praktyczna 2003;4(2):111-124.

The role of individual criteria in the assessment of metabolic syndrome control in the DINAMIC study (IV)

Teresa Kasperska-Czyżyk, Władysław Grzeszczak, Jacek Sieradzki, Marcin Szczepański oraz Zespół Badaczy DINAMIC

Diabetologia Praktyczna 2003;4(2):125-132.

Application of gliclazide MR in uncontrolled diabetes type 2 — the treatment phase results of DINAMIC 2 study (V)

Jacek Sieradzki, Teresa Kasperska-Czyżyk, Władysław Grzeszczak oraz Zespół Badaczy DINAMIC

Diabetologia Praktyczna 2003;4(2):133-136.

Vitamin D receptor gene polymorphisms and the risk of coronary artery disease in a Polish population with type 2 diabetes mellitus and with normal glucose metabolism

Maciej T. Małecki, Jan Skupień, Małgorzata Waluś, Małgorzata Owczarek, Wojciech Czogała, Przemysław Miarka, Tomasz Klupa, Jacek Sieradzki

Diabetologia Praktyczna 2003;4(2):137-144.
Review articles (submitted)

Endothelial dysfunction in diabetes — therapeutic possibilities

Bogna Wierusz-Wysocka

Diabetologia Praktyczna 2003;4(2):145-152.

Recent progress in diabetic trombophilia prophylaxis and treatment

Ida Kinalska, Beata Telejko

Diabetologia Praktyczna 2003;4(2):153-160.
Original articles (translated)

Hypertension management in patients with diabetes. The need for more aggressive therapy

Dan R. Berlowitz, Arlene S. Ash, Elaine C. Hickey, Mark Glickman, Robert Friedman, Boris Kader

Diabetologia Praktyczna 2003;4(2):161-168.

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

Philippe Vague, Jean-Louis Selam, Svein Skeie, Ivo De Leeuw, Jan W.F. Elte, Hanne Haahr, Allan Kristensen, Eberhard Draeger

Diabetologia Praktyczna 2003;4(2):169-177.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.


Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl